Avient Croissance future
Future contrôle des critères 1/6
Avient devrait augmenter ses bénéfices et son chiffre d'affaires de 16.4% et de 3.8% par an respectivement. Le BPA devrait croître de de 16.1% par an. Le rendement des capitaux propres devrait être 10.3% dans 3 ans.
Informations clés
16.4%
Taux de croissance des bénéfices
16.11%
Taux de croissance du BPA
| Chemicals croissance des bénéfices | 17.2% |
| Taux de croissance des recettes | 3.8% |
| Rendement futur des capitaux propres | 10.30% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 20 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour du récit • Apr 22
AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential
Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.Mise à jour du récit • Apr 08
AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential
Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.Mise à jour du récit • Mar 24
AVNT: Future Commodity Cost Management Will Drive ReRating Potential
Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-forwards.Mise à jour du récit • Mar 08
AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares
Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.Mise à jour du récit • Feb 21
AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple
The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.Article d’analyse • Feb 19
There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings
Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...Seeking Alpha • Feb 18
Avient: Becoming A Better Business
Summary Avient has demonstrated solid operating momentum and resilient execution, with shares enjoying a notable re-rating amid challenging industry conditions. Avient's 2026 outlook targets adjusted EBITDA of $555–$585 million and an adjusted EPS midpoint of $3.05, driven by productivity and innovation, not macro recovery. Leverage has improved to 2.6x, and valuation has expanded to 14x adjusted earnings, reflecting investor confidence in management's strategy and product pipeline. Despite a 30% share price gain in six months, Avient remains reasonably valued, but further upside may prompt position trimming on strength. Read the full article on Seeking Alpha
Nouveau récit • Feb 16
Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook
Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?Mise à jour du récit • Feb 06
AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple
Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.Mise à jour du récit • Jan 23
AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential
Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.Mise à jour du récit • Jan 08
AVNT: Reset Price View Will Support Future Multiple Expansion
Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.Mise à jour du récit • Dec 23
AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion
Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.Mise à jour du récit • Dec 09
AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease
Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.Mise à jour du récit • Nov 24
AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead
Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.Mise à jour du récit • Nov 07
AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets
Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.Article d’analyse • Nov 05
Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275
The board of Avient Corporation ( NYSE:AVNT ) has announced that the dividend on 7th of January will be increased to...Article d’analyse • Oct 12
Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.275 on...Mise à jour du récit • Sep 18
High-Performance Healthcare Materials And Sustainable Polymers Will Create Value
Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.Article d’analyse • Sep 13
Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors
With a price-to-earnings (or "P/E") ratio of 27.9x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Article d’analyse • Jul 14
Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?
Key Insights Avient's estimated fair value is US$48.56 based on 2 Stage Free Cash Flow to Equity Current share price of...Article d’analyse • May 23
Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?
Avient Corporation ( NYSE:AVNT ), might not be a large cap stock, but it saw a significant share price rise of 25% in...Article d’analyse • May 08
Is Avient (NYSE:AVNT) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Apr 07
Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?
Key Insights Avient's estimated fair value is US$60.06 based on 2 Stage Free Cash Flow to Equity Avient's US$30.43...Article d’analyse • Mar 23
Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E
With a price-to-earnings (or "P/E") ratio of 20.7x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Seeking Alpha • Mar 22
Avient: Specialty Play Slowly Becomes More Special
Summary Avient Corporation has returned to growth in 2024, with promising projections for 2025, despite past disappointments and mixed earnings metrics. The company, specializing in material solutions, aims for organic growth and 20% EBITDA margins, but hasn't yet achieved these targets. Trading at $38 per share, Avient's valuation appears reasonable, but earnings will again be highly adjusted due to significant charges. While the 2025 outlook is strong, I remain cautious and seek a better entry point before initiating a long position. Read the full article on Seeking AlphaArticle d’analyse • Feb 19
At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?
While Avient Corporation ( NYSE:AVNT ) might not have the largest market cap around , it saw a decent share price...Article d’analyse • Jan 20
Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Article d’analyse • Jan 03
An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued
Key Insights Avient's estimated fair value is US$57.96 based on 2 Stage Free Cash Flow to Equity Avient is estimated to...Article d’analyse • Dec 18
Earnings Tell The Story For Avient Corporation (NYSE:AVNT)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...Article d’analyse • Nov 18
Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?
Avient Corporation ( NYSE:AVNT ), is not the largest company out there, but it saw a decent share price growth of 13...Seeking Alpha • Nov 13
Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth
Summary AVNT's gross profit margins have improved by over 70% in the last decade, indicating a shift to higher-margin specialty services. The company is focused on deleveraging, with share repurchases on hold until net debt-to-EBITDA reaches 2.5x, despite recent acquisitions. AVNT announced its 14th consecutive annual dividend increase, with a 5% hike, and aims to return to a safer payout ratio by 2026. With projected double-digit EPS growth and a potential P/E Ratio of 20.6x, AVNT is rated as a BUY with an estimated share price of $61.80 by the 2025 year-end. Read the full article on Seeking AlphaArticle d’analyse • Nov 02
Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.27 on...Article d’analyse • Sep 26
Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Nouveau récit • Sep 02
Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth
Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.Article d’analyse • Aug 03
A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)
Key Insights Avient's estimated fair value is US$37.54 based on 2 Stage Free Cash Flow to Equity With US$42.83 share...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 3,652 | 264 | 258 | 428 | 4 |
| 12/31/2027 | 3,504 | 232 | 236 | 377 | 7 |
| 12/31/2026 | 3,379 | 232 | 194 | 324 | 8 |
| 3/31/2026 | 3,281 | 158 | 205 | 318 | N/A |
| 12/31/2025 | 3,260 | 82 | 195 | 302 | N/A |
| 9/30/2025 | 3,246 | 113 | 151 | 256 | N/A |
| 6/30/2025 | 3,255 | 119 | 150 | 255 | N/A |
| 3/31/2025 | 3,238 | 100 | 139 | 249 | N/A |
| 12/31/2024 | 3,240 | 170 | 135 | 257 | N/A |
| 9/30/2024 | 3,213 | 149 | 164 | 289 | N/A |
| 6/30/2024 | 3,151 | 116 | 160 | 289 | N/A |
| 3/31/2024 | 3,126 | 104 | 58 | 181 | N/A |
| 12/31/2023 | 3,143 | 76 | 82 | 202 | N/A |
| 9/30/2023 | 3,214 | 31 | 96 | 222 | N/A |
| 6/30/2023 | 3,284 | -1 | 150 | 267 | N/A |
| 3/31/2023 | 3,350 | 39 | 245 | 357 | N/A |
| 12/31/2022 | 3,397 | 83 | 293 | 398 | N/A |
| 9/30/2022 | 3,414 | 108 | 255 | 348 | N/A |
| 6/30/2022 | 3,408 | 169 | 180 | 272 | N/A |
| 3/31/2022 | 3,045 | 137 | 152 | 249 | N/A |
| 12/31/2021 | 3,316 | 152 | 133 | 234 | N/A |
| 9/30/2021 | 3,506 | 218 | 175 | 263 | N/A |
| 6/30/2021 | 3,612 | 186 | 129 | 214 | N/A |
| 3/31/2021 | 3,693 | 178 | 169 | 238 | N/A |
| 12/31/2020 | 2,215 | 71 | 158 | 222 | N/A |
| 9/30/2020 | 2,904 | 64 | 99 | 171 | N/A |
| 6/30/2020 | 2,685 | 86 | 201 | 277 | N/A |
| 3/31/2020 | 2,824 | 86 | 230 | 313 | N/A |
| 12/31/2019 | 2,863 | 76 | N/A | 301 | N/A |
| 9/30/2019 | 2,881 | 68 | N/A | 281 | N/A |
| 6/30/2019 | 2,905 | 77 | N/A | 244 | N/A |
| 3/31/2019 | 2,730 | 62 | N/A | 202 | N/A |
| 12/31/2018 | 2,881 | 88 | N/A | 254 | N/A |
| 9/30/2018 | 3,005 | 124 | N/A | 262 | N/A |
| 6/30/2018 | 3,094 | 132 | N/A | 268 | N/A |
| 3/31/2018 | 3,335 | 173 | N/A | 253 | N/A |
| 12/31/2017 | 2,590 | 111 | N/A | 202 | N/A |
| 9/30/2017 | 3,124 | 173 | N/A | 206 | N/A |
| 6/30/2017 | 3,052 | 176 | N/A | 217 | N/A |
| 3/31/2017 | 2,996 | 176 | N/A | 227 | N/A |
| 12/31/2016 | 2,939 | 166 | N/A | 228 | N/A |
| 9/30/2016 | 3,020 | 134 | N/A | 231 | N/A |
| 6/30/2016 | 3,115 | 136 | N/A | 222 | N/A |
| 3/31/2016 | 3,243 | 153 | N/A | 262 | N/A |
| 12/31/2015 | 2,929 | 148 | N/A | 240 | N/A |
| 9/30/2015 | 3,471 | 127 | N/A | 205 | N/A |
| 6/30/2015 | 3,588 | 115 | N/A | 225 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de AVNT ( 16.4% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de AVNT ( 16.4% par an) devraient croître plus lentement que le marché US ( 16.8% par an).
Croissance élevée des bénéfices: Les bénéfices de AVNT devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de AVNT ( 3.8% par an) devrait croître plus lentement que le marché de US ( 11.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de AVNT ( 3.8% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de AVNT devrait être faible dans 3 ans ( 10.3 %).
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/24 16:22 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Avient Corporation est couverte par 18 analystes. 8 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Ghansham Panjabi | Baird |
| Prashant Juvekar | Citigroup Inc |
| David Begleiter | Deutsche Bank |